» Articles » PMID: 2474611

Influence of Adjuvants on the Quantity, Affinity, Isotype and Epitope Specificity of Murine Antibodies

Overview
Publisher Elsevier
Date 1989 Jul 26
PMID 2474611
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Five adjuvants were compared to Freund's adjuvant for production of mouse polyclonal antibodies and monoclonal antibodies (McAbs) to human serum albumin (HSA) and interleukin-1 alpha (IL-1 alpha). Parameters examined were titer, affinity, concentration, isotype, epitope specificity and neutralizing activity of sera and hybridoma supernatants. Freund's adjuvant, while producing high titers and concentrations of antibodies in sera, was inferior to other adjuvants for eliciting antibodies with particular qualities. The adjuvants Quil A and A1(OH)3/[Thr1]muramyldipeptide elicited the highest affinity antibodies to HSA. Syntex adjuvant formulation-1 (SAF-1) elicited the highest percentage of 'protective' IgG2a antibodies to HSA. All adjuvants, particularly Quil A and Ribi adjuvant system, where superior to Freund's adjuvant in eliciting antibodies which bound native versus denatured HSA. In a comparison of SAF-1 and Freund's adjuvant, SAF-1 was superior to Freund's adjuvant in eliciting polyclonal and hybridoma antibodies which neutralized the biological activity of IL-1 alpha. These results show that adjuvants selectively and independently enhance different qualities of the antibody response. Furthermore, immunization with the appropriate adjuvant can optimize production of McAbs with desired qualities.

Citing Articles

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of in murine model.

da Silva Matos A, Soares I, Rodrigues-da-Silva R, Rodolphi C, Albrecht L, Donassolo R Front Immunol. 2024; 15:1392043.

PMID: 38962015 PMC: 11219565. DOI: 10.3389/fimmu.2024.1392043.


Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to in Mice and Non-Human Primates.

Ryan N, Hess J, Robertson E, Tricoche N, Turner C, Davis J Vaccines (Basel). 2023; 11(7).

PMID: 37515028 PMC: 10385774. DOI: 10.3390/vaccines11071212.


B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs.

Gavitt T, Mara A, Goodridge M, Ozyck R, Reinhardt E, Miller J NPJ Vaccines. 2022; 7(1):130.

PMID: 36310317 PMC: 9618410. DOI: 10.1038/s41541-022-00556-z.


Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.

St John A, Choi H, Walker Q, Blough B, Kuhn C, Abraham S NPJ Vaccines. 2020; 5(1):12.

PMID: 32047657 PMC: 7002721. DOI: 10.1038/s41541-020-0161-1.


The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Hess J, Zhan B, Torigian A, Patton J, Petrovsky N, Zhan T PLoS Negl Trop Dis. 2016; 10(7):e0004797.

PMID: 27387453 PMC: 4936747. DOI: 10.1371/journal.pntd.0004797.